Stock Analysis

Healwell AI Inc.'s (TSE:AIDX) Shift From Loss To Profit

TSX:AIDX
Source: Shutterstock

With the business potentially at an important milestone, we thought we'd take a closer look at Healwell AI Inc.'s (TSE:AIDX) future prospects. Healwell AI Inc., a healthcare technology company, focuses on AI and data science for preventative care. The CA$267m market-cap company posted a loss in its most recent financial year of CA$32m and a latest trailing-twelve-month loss of CA$20m shrinking the gap between loss and breakeven. Many investors are wondering about the rate at which Healwell AI will turn a profit, with the big question being “when will the company breakeven?” In this article, we will touch on the expectations for the company's growth and when analysts expect it to become profitable.

See our latest analysis for Healwell AI

Healwell AI is bordering on breakeven, according to the 7 Canadian Healthcare analysts. They anticipate the company to incur a final loss in 2025, before generating positive profits of CA$9.3m in 2026. The company is therefore projected to breakeven just over a year from today. How fast will the company have to grow each year in order to reach the breakeven point by 2026? Working backwards from analyst estimates, it turns out that they expect the company to grow 92% year-on-year, on average, which is extremely buoyant. Should the business grow at a slower rate, it will become profitable at a later date than expected.

earnings-per-share-growth
TSX:AIDX Earnings Per Share Growth March 20th 2025

Underlying developments driving Healwell AI's growth isn’t the focus of this broad overview, but, keep in mind that typically a high forecast growth rate is not unusual for a company that is currently undergoing an investment period.

One thing we’d like to point out is that The company has managed its capital prudently, with debt making up 20% of equity. This means that it has predominantly funded its operations from equity capital, and its low debt obligation reduces the risk around investing in the loss-making company.

Next Steps:

This article is not intended to be a comprehensive analysis on Healwell AI, so if you are interested in understanding the company at a deeper level, take a look at Healwell AI's company page on Simply Wall St. We've also put together a list of important aspects you should further research:

  1. Valuation: What is Healwell AI worth today? Has the future growth potential already been factored into the price? The intrinsic value infographic in our free research report helps visualize whether Healwell AI is currently mispriced by the market.
  2. Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on Healwell AI’s board and the CEO’s background.
  3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.

If you're looking to trade Healwell AI, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.

With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.

Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.

Sponsored Content

Valuation is complex, but we're here to simplify it.

Discover if Healwell AI might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.